Baupost Group

Baupost Group

13F Holdings and Portfolio Analysis

Seth Klarman 2017 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.

Baupost Group Overview

Baupost Group held 37 stocks in 2017 Q3, with total market value around $8.02B.

Baupost Group's top five holdings in 2017 Q3: CHENIERE ENERGY INC 11.64%, Synchrony Financial(SYF) 11.34%, VIASAT INC(VSAT) 10.55%, QORVO INC 7.93%, ALLERGAN PFD CONV SER A 7.57%.

Portfolio Value
$8.02B
Current Holdings
37 stocks
New / Increased
5 / 7
Reduced / Exited
4 / 9

Current Holdings

1CHENIERE ENERGY INCCUSIP 16411R2080.9311.64%20.73 -$45.04- $42.980.003.75+$0.04B+4.80%Held
2Synchrony FinancialSYF0.9111.34%29.30 -$31.05$72.84 +134.59%$29.470.001.25+$1.27B+147.16%Held
3VIASAT INCVSAT0.8510.55%13.16 -$64.32- $70.540.004.50-$0.08B-8.81%Held
4QORVO INCCUSIP 74736K1010.647.93%9.00 -$70.68- $67.500.000.75+$0.03B+4.71%Held
5ALLERGAN PFD CONV SER ACUSIP G0177J1080.617.57%2.96 +21.85%$204.95- $327.27+0.531.75-$0.36B-37.38%Increased
6COLONY NORTHSTAR INCCUSIP 19625W1040.607.50%47.91 -$12.56- $12.910.000.75-$0.02B-2.71%Held
7TWENTY FIRST CENTY FOX INC CL AFOXA0.506.29%19.14 -$26.38- $26.770.002.25-$0.01B-1.48%Held
8ANTERO RES CORPCUSIP 03674X1060.485.93%23.91 +12.95%$19.90- $16.62+2.743.25+$0.08B+19.72%Increased
9PBF ENERGY INCCUSIP 69318G1060.435.41%15.72 -$27.61- $25.230.004.25+$0.04B+9.42%Held
10THERAVANCE BIOPHARMA INCCUSIP G8807B1060.323.97%9.31 +0.38%$34.24- $30.35+0.043.50+$0.04B+12.81%Increased
11DELL TECHNOLOGIES INCCUSIP 24703L1030.242.94%3.05 -46.00%$77.21- $47.80-2.601.25+$0.09B+61.53%Reduced
12TWENTY FIRST CENTY FOX INC CL BCUSIP 90130A2000.192.37%7.38 +1.46%$25.79- $27.17+0.112.25-$0.01B-5.07%Increased
13KERYX BIOPHARMACEUTICALS INCCUSIP 4925151010.182.28%25.79 -$7.10- $14.160.003.75-$0.18B-49.87%Held
14CARDINAL HEALTH INCCAH0.172.11%2.53 +24.63%$66.92- $73.32+0.501.00-$0.02B-8.73%Increased
15EXPRESS SCRIPTS HLDG CO COMESRX0.162.02%2.56 -$63.32- $64.830.000.75-$0.00B-2.34%Held
16VERITIV CORPCUSIP 9234541020.101.24%3.05 +0.31%$32.50- $46.69+0.013.25-$0.04B-30.39%Increased
17ATARA BIOTHERAPEUTICS INCCUSIP 0465131070.091.11%5.36 -$16.55- $31.840.003.00-$0.08B-48.02%Held
18MCKESSON CORP COMMCK0.080.96%0.50 $153.61$742.44 +383.33%$153.61+0.500.25+$0.29B+383.33%New
19PARATEK PHARMACEUTICALS INCCUSIP 6993743020.060.75%2.39 -$25.10- $29.510.003.00-$0.01B-14.95%Held
20CHIPMOS TECHNOLOGIES INCCUSIP 16965P1030.060.73%3.05 -13.15%$19.32- $14.11-0.461.00+$0.02B+36.92%Reduced
21AMC ENTMT HLDGS INCCUSIP 00165C1040.050.65%3.57 $14.70- $14.70+3.570.25$0.00B0.00%New
22GTY TECHNOLOGY HOLDINGS INCCUSIP G4182A1100.050.57%4.40 -$10.46- $10.500.001.00-$0.00B-0.38%Held
23CENTENNIAL RESOURCE DEV INCCUSIP 15136A1020.040.52%2.41 -$17.48- $18.100.001.00-$0.00B-3.40%Held
24AVIS BUDGET GROUPCUSIP 0537741050.040.49%1.04 -74.08%$38.06- $106.55-2.960.50-$0.07B-64.28%Reduced
25FORWARD PHARMA A/SCUSIP 34986J1050.040.49%6.46 +1.56%$6.07- $20.56+0.103.00-$0.09B-70.48%Increased
Showing 1-25 of 37

"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.

Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.

Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.

Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.

Exited Holdings

Stocks no longer disclosed in the current 13F portfolio for 2017 Q3.

1QUALCOMM IncorporatedQCOM5.220.50$57.34$51.84-$0.03B-9.59%
2SPIRIT RLTY CAP INC NEWCUSIP 84860W1029.000.25$7.41$7.41$0.00B0.00%
3CONYERS PK ACQUISITIONCUSIP 2128941093.711.00$10.00$11.78+$0.01B+17.80%
4LIBERTY BRAVES GROUP COMMON STOCKCUSIP 5312298881.301.25$14.66$25.27+$0.01B+72.37%
5CREDIT ACCEP CORP MICH COMCACC0.101.25$204.24$280.17+$0.01B+37.18%
6THERAVANCE INC CV SUB NTCUSIP 88338TAB0可转换债券16.983.00$0.86$0.97+$0.00B+13.48%
7AMERICAN INTL GROUP INCCUSIP 0268741560.354.25$16.22$21.08+$0.00B+29.92%
8SILVER RUN ACQUISITIONCUSIP 82812A1112.210.25$1.79$1.79$0.00B0.00%
9CONYERS PK ACQUISITIONCUSIP 2128941171.241.00$1.15$2.62+$0.00B+127.83%
Showing 1-9 of 9

Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.

"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.

Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.

Exit return shows estimated dollar return on top and percentage return below.

Portfolio Visuals

Track portfolio value, position weights and Top 10 history.

Market Value Trend ($B)

52 periods

Position Weight

TOP10

Holding Changes ($B)

All-period Top 10

Top 10 Holdings Replay

Animated view